SCHEMBL4856565

SCHEMBL4856565

Nc1ccc(Oc2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.83
HTT P42858 2/20 0.83
CA2 P00918 9/20 0.74
CA9 Q16790 9/20 0.74
CA12 O43570 8/20 0.74
CA1 P00915 8/20 0.74
CA14 Q9ULX7 4/20 0.74
TSHR P16473 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
CA7 P43166 2/20 0.74
USP2 O75604 1/20 0.74
CA4 P22748 1/20 0.74
CA6 P23280 1/20 0.74
CA5A P35218 1/20 0.74
CA13 Q8N1Q1 1/20 0.74
AGO2 Q9UKV8 1/20 0.74
CA5B Q9Y2D0 1/20 0.74
SOS1 Q07889 4/20 0.70
CYP3A4 P08684 1/20 0.61
MAOA P21397 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2213483 0.91 ALDH1A1 (1.00) ALDH1A1HTTCA2CA9CA12
SCHEMBL30886713 0.89 ALDH1A1 (0.66) ALDH1A1HTTCA2CA9CA12
SCHEMBL29210281 0.89 HTT (0.66) ALDH1A1HTTCA2CA9CA12
Sulfanilamide SCHEMBL740 0.86 CA2 (1.00) ALDH1A1HTTCA2CA9CA12
Sulfanilamide SCHEMBL30659052 0.86 CA2 (1.00) ALDH1A1HTTCA2CA9CA12
Sulfanilamide SCHEMBL2798899 0.86 CA2 (1.00) ALDH1A1HTTCA2CA9CA12
Sulfanilamide SCHEMBL31544839 0.86 CA2 (1.00) ALDH1A1HTTCA2CA9CA12
SCHEMBL7460220 0.84 TSHR (0.73) ALDH1A1HTTCA2CA9CA12
SCHEMBL65653 0.84 TSHR (0.73) ALDH1A1HTTCA2CA9CA12
SCHEMBL203972 0.84 TSHR (0.73) ALDH1A1HTTCA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118290794-A Coating type modified polyimide film with carrier film and preparation method thereof 昆山雅森电子材料科技有限公司 2024-07-05 CN claimed
CN-117984624-A High-heat-conductivity metal substrate and preparation method thereof 昆山雅森电子材料科技有限公司 2024-05-07 CN claimed
CN-117769109-A High-heat-conductivity metal substrate and preparation method thereof 昆山雅森电子材料科技有限公司 2024-03-26 CN claimed
CN-117586542-A Polyimide film with carrier layer and preparation method thereof 昆山雅森电子材料科技有限公司 2024-02-23 CN claimed
CN-115696893-B High-shielding PI type electromagnetic interference shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-12-08 CN claimed
CN-116693911-A Composite film and method for producing same 昆山雅森电子材料科技有限公司 2023-09-05 CN claimed
CN-115558436-B High-performance polyimide shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-08-01 CN claimed
CN-115696893-A High-shielding PI type electromagnetic interference shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-02-03 CN claimed
CN-115558436-A High-performance polyimide shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-01-03 CN claimed
CN-118290794-A Coating type modified polyimide film with carrier film and preparation method thereof 昆山雅森电子材料科技有限公司 2024-07-05 CN disclosed
CN-117984624-A High-heat-conductivity metal substrate and preparation method thereof 昆山雅森电子材料科技有限公司 2024-05-07 CN disclosed
CN-117769109-A High-heat-conductivity metal substrate and preparation method thereof 昆山雅森电子材料科技有限公司 2024-03-26 CN disclosed
CN-117586542-A Polyimide film with carrier layer and preparation method thereof 昆山雅森电子材料科技有限公司 2024-02-23 CN disclosed
CN-115696893-B High-shielding PI type electromagnetic interference shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-12-08 CN disclosed
CN-115696893-A High-shielding PI type electromagnetic interference shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-02-03 CN disclosed
CN-115558436-A High-performance polyimide shielding film and preparation method thereof 昆山雅森电子材料科技有限公司 2023-01-03 CN disclosed
US-7384963-B2 2′-Methyl-5-(1,3,4-oxadiazol-2-yl)1, 1′-biphenyl-4-carboxaide derivatives and their use as p38 kinase GLAXO GROUP LIMITED (GB) 2008-06-10 US disclosed
US-20040266839-A1 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors GLAXO GROUP LIMITED (GB) 2004-12-30 US disclosed
EP-1435949-A1 2' -METHYL-5-(1,3,4-OXADIAZOL-2-YL)-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-07-14 EP disclosed
WO-2003032986-A1 2' -METHYL-5-(1,3,4-OXADIAZOL-2-YL)-1,1'-BIPHENYL-4-CARBOXAMIDE DERIVATIVES AND THEIR USE AS P38 KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266839-A1 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors MAPK1, MAPK3, MAPK6 ALDH1A1 1805/4885HTT 4641/4885CA2 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.